Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 324

1.

[Secondary prevention with clopidogrel after TIA or stroke].

Zuurbier SM, Vermeer SE, Hilkens PH, Algra A, Roos YB.

Ned Tijdschr Geneeskd. 2013;157(25):A5836. Review. Dutch.

PMID:
23777963
2.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
3.
4.
6.

Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

Kirshner HS.

Int J Clin Pract. 2007 Oct;61(10):1739-48. Review. Erratum in: Int J Clin Pract. 2007 Nov;61(11):1957.

7.

[Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].

Sander D, Schwertfeger M, Köfüncü E, Diehm C, Pittrow D.

Dtsch Med Wochenschr. 2008 Sep;133(36):1773-8. doi: 10.1055/s-0028-1082810. Epub 2008 Sep 2. German.

PMID:
18767003
8.

Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.

Simmons BB, Yeo A, Fung K; American Heart Association; American Stroke Association.

Postgrad Med. 2010 Mar;122(2):49-53. doi: 10.3810/pgm.2010.03.2121. Review.

PMID:
20203455
9.

Antiplatelet therapy for transient ischemic attack.

Acelajado MC, Oparil S.

J Clin Hypertens (Greenwich). 2012 Feb;14(2):103-11. doi: 10.1111/j.1751-7176.2011.00571.x. Epub 2012 Jan 4.

10.

Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?

Aw D, Sharma JC.

Postgrad Med J. 2012 Jan;88(1035):34-7. doi: 10.1136/postgradmedj-2011-130100. Epub 2011 Nov 25. Review.

PMID:
22121248
11.

Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?

Diener HC.

Int J Stroke. 2006 Feb;1(1):4-8. doi: 10.1111/j.1747-4949.2005.00016.x.

PMID:
18706062
12.

Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.

Biller J.

J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19. Review.

PMID:
19380153
13.

Prevention of ischaemic stroke--antiplatelets.

McCabe DJ, Brown MM.

Br Med Bull. 2000;56(2):510-25. Review.

PMID:
11092100
15.

Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.

Guthrie R.

Adv Ther. 2011 Jun;28(6):473-82. doi: 10.1007/s12325-011-0026-0. Epub 2011 May 3. Review.

PMID:
21547541
16.

Antiplatelet agents and randomized trials.

Diener HC.

Rev Neurol Dis. 2007 Fall;4(4):177-83. Review.

PMID:
18195669
18.

Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.

Davis KA, Miyares MA, Dietrich E.

Am J Health Syst Pharm. 2015 Oct 1;72(19):1623-9. doi: 10.2146/ajhp140804. Review.

PMID:
26386103
19.

Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).

Kinsella JA, Tobin WO, Cox D, Coughlan T, Collins R, O'Neill D, Murphy RP, McCabe DJ.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e84-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.07.012. Epub 2012 Sep 13.

PMID:
22981273
20.

[Antithrombotic therapy in ischemic stroke and transient ischemic attack].

Overgaard K, Poulsen TS, Husted SE.

Ugeskr Laeger. 2007 Oct 1;169(40):3379-82. Danish.

PMID:
17953858

Supplemental Content

Support Center